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Background: Oral neural tumors (ONTs) are rare lesions and represent reactive or neoplastic proliferations of nerve 
sheath cells. The purpose of the present study is to report the clinical, demographic and histopathologic features of 
157 ONTs diagnosed in a single Oral Pathology Department and review the pertinent literature.
Material and Methods: 157 cases of ONTs diagnosed during a 44-year period were retrospectively collected and the 
diagnosis was reconfirmed by studying representative haematoxylin and eosin stained tissue sections. The patients’ 
gender and age, as well as the main clinical features of the lesions, were retrieved from the biopsy submission 
forms.
Results: The 157 ONTs represented approximately 0.4% of 35,590 biopsies accessioned during the study period. 
They affected 71 male and 86 female patients with a mean age of 38.4±18.8 years. They mainly appeared as asymp-
tomatic nodules of normal or white colour on the tongue, lip mucosa and hard palate. The most common ONT 
was granular cell tumour (38.9%) followed by neurofibroma (19.7%), schwannoma (15.9%), traumatic neuroma 
(15.9%), palisaded encapsulated neuroma (8.3%) and nerve sheath myxoma (1.3%).
Conclusions: This study confirmed the rarity of ONTs. Their clinical characteristics mimic other oral lesions; thus, 
microscopic examination is the only mean to arrive at a definitive diagnosis.
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Introduction
Oral neural tumors (ONTs) may be either neoplastic or 
reactive in origin (1) and they arise from distinguishable 
compartments of peripheral nerves, which are the axons, 
endoneurium, perineurium and epineurium (2,3). The 
endoneurium comprises of fibroblasts, capillaries, ma-
crophages and mast cells and surrounds axons which are 
formed by Schwann cells (2,3). The perineurium con-
sists of perineurial cells arranged in one or more concen-
tric layers with collagen fibers (4) while the epineurium 
is mainly comprised of fibro adipose tissue (2). ONTs 
are rare lesions (5-10). Jones and Franklin (6) reported 
387 (0.88%) cases of benign and no case of malignant 
ONTs in patients over 16 years old, amongst 44,007 oral 
and maxillofacial pathology specimens submitted for 
histopathologic examination during a 30-year period. 
In patients younger than 16 years old, benign periphe-
ral nerve sheath tumors comprised 0.7% and malignant 
neural tumors 0.02% of 4406 specimens of oral and 
maxillofacial pathology specimens submitted for histo-
pathologic examination during a 30-year period (7). In 
a recent study (10), Alotaibi et al., reported 340 (0.2%) 
cases of benign and no case of malignant ONTs amongst 
164,578 specimens during a 22-year period. 
The most common ONTs are neurofibroma (NF), trauma-
tic neuroma (TN), schwannoma (SCH) or neurilemmo-
ma and palisaded encapsulated neuroma (PEN) (5-13). 
However, in rare occasions other peripheral nerve sheath 
tumors may appear in the oral cavity. They may be be-
nign, such as nerve sheath myxoma (NSM) (14), neuro-
thekeoma (15) perineurioma (4), or malignant (16). The 
diagnosis of ONTs may be challenging due to overlap of 
histologic features and use of immunohistochemical mar-
kers may be essentials to set a definite diagnosis (11). 
In the latest WHO classification of Head and Neck Tu-
mors (17), oral granular cell tumor (GCT) is defined as 
an “uncommon benign tumor of Schwann- cell diffe-
rentiation characterized by poorly demarcated accumu-
lation of plump granular cells”. The schwannian diffe-
rentiation can be justified by the intense reactivity for 
the immunohistochemical marker S-100 (17).  However, 
Vered et al. (18), showed that oral GCT express a variety 
of immunohistochemical markers besides S-100 sugges-
ting that they do not derive from a particular cell type. 
Additionally, few cases of oral GCT are S-100 negative 
(primitive polypoid granular cell tumors) (19,20). Ne-
vertheless, following the latest WHO classification (17) 
and the opinion of other authors (5-11), oral GCT, will 
be considered an ONT in the present study. 
The purpose of the present study is to describe the cli-
nicopathological features of 157 ONTs and review the 
pertinent literature.
Material and Methods
All cases of ONTs diagnosed from 1974 to 2017 were 
retrospectively retrieved from the files of the Depart-
ment of Oral Medicine and Pathology. The diagnosis in 
each case was reconfirmed by studying representative 
5μm - hematoxylin and eosin stained tissue sections. 
From the biopsy submission forms the following data 
were collected: age and gender of patients, site, clini-
cal description, size, color, symptoms and duration of 
each lesion. All data were aggregated and tabulated 
using Microsoft Excel® 2016. The study was approved 
by the Research Ethics Committee of the Department 
of Dentistry, School of Health Sciences, National and 
Kapodistrian University of Athens, Greece (code num-
ber 371/11.07.2018).
Results
Out of 35,590 biopsies accessioned during the study 
period, 157 cases of ONTs in equivalent number of pa-
tients were detected representing approximately 0.4% of 
the whole sample. The most common ONT was GCT 
(38.9%) followed by NF (19.7%), SCH (15.9%), TN 
(15.9%), PEN (8.3%) and NSM (1.3%). No case of ma-
lignant ONT was retrieved. 
Gender was recorded in 157 cases whereas age in 155. 
All demographic characteristics are tabulated in Table 1 
whereas the number of patients in each decade of life is 
illustrated in Figure 1.  As a whole, ONTs had a slight fe-
male predominance with a male to female ratio of 0.8:1. 
The majority of patients were in the 3rd and 4th deca-
de of life with a mean age of 38.4±18.8 years (median 
age: 36 years). Amongst ONTs, GCT, SCH and TN had 
the lowest male to female ratio whereas NF the highest. 
In addition, with the exceptions of NF, which occurred 
in younger female compared to male patients, all other 
neural tumors occurred in approximately the same aged 
patients, irrespectively of gender. 
The exact location of lesions was recorded in 154 cases 
and has been tabulated in Table 2. As a whole, ONTs 
more commonly occurred in the tongue (52.5%), fo-
llowed in descending order by lip mucosa (12.3%) and 
hard palate (11.7%). GCT, SCH and TNM also more 
commonly occurred on the tongue. NF manifested with 
the same frequency in the tongue (23.3%) and hard pala-
te (23.3%) whereas PEN in the hard palate (38.5%) and 
lip mucosa (30.8%). 
The clinical characteristics of all ONTs are tabulated in 
Table 3. As a whole, ONTs were clinically described as 
nodules in 94.2% of cases. The majority of ONTs were 
of normal (58.6%) or white (29.3%) color, measuring 
1±0.7 cm in their maximum diameter. The majority of 
lesions (85.6%) were asymptomatic thus justifying the 
long duration of 25±35.5 months. SCH had the grea-
ter size of all ONTs; NF was the ONT presenting more 
commonly with symptoms; GCT had the shortest and 
PEN the highest duration among ONTs of the sample. 
The clinical characteristics of ONTs are non-specific and 
J Clin Exp Dent. 2019;11(8):e721-31.                                                                                                                                                                                                                            Oral neural tumors
e723
Fig. 1: Number of patients in each decade of life for all ONTs.
Diagnosis Number 
of lesions 
(% of all 
lesions) 









Mean age of male 
patients in years 
(median) [range] 
Mean age of female 
patients in years 
(median) [range] 
All ONTs 157 (100) Male:71 (45.2) 
Female:86 (54.8) 
0.8:1 38.4±18.8 (36) 
[2 – 95] 
39.4±17.9 (37) [9 
- 89] 
37.6±19.4 (35) [2 - 95] 
Granular cell 
tumor 
61 (38.9) Male:25 (41) 
Female: 36 (59) 
0.7:1 38.1±14.3 (38) 
[9.5 – 73] 
37.8±13.9 (39) [13 
- 64] 
38.3±14.5 (36) [9.5 - 73] 
Neurofibroma 31 (19.7) Male:18 (58.1) 
Female: 13 (41.9) 
1.4:1 40±21.4 (36) 
[2-89] 
45.1±21.9 (41.5) 
[14 - 89] 
33.1±18.6 (34) [2 - 70] 
Schwannoma 25 (15.9) Male:10 (40) 
Female: 15 (60) 
0.7:1 32±18.7 (26) 
[9-75] 
31.3±16.8 (27.5) 
[9 – 67] 
32.4±19.8 (25) [12 – 75] 
Traumatic 
neuroma 
25 (15.9) Male:10 (40) 
Female: 15 (60) 
0.7:1 39.6±23.2 (39) 
[9–95] 
37.4±18.6 (34.5) 
[17 – 75] 




13 (8.3) Male:7 (53.8) 
Female: 6 (46.2) 
1.2:1 45.7±16.7  (45) 
[9 – 75] 
47.4±11.3 (46) [36 
– 64] 
43.7±21.1 (44.5) [9 - 75] 
Nerve sheath 
myxoma 
2 (1.3) 1 male patient 24 years old and 1 female patient  61 years old 
 
Table 1: Demographic characteristics of 157 ONTs.
mimic those of other oral lesions that is why the most 
common provisional diagnosis recorded was irritation 
fibroma (30.1%). The most common provisional diagno-
sis for each ONT was: GCT for GCT; irritation fibroma 
for NF, TN and PEN; lipoma and benign salivary gland 
tumor for SCH;. 
Concerning histopathological characteristics, pseu-
doepitheliomatous hyperplasia was noticed in 30 
(49.2%) cases of GCT; 25 (80.6%)  NFs were diagno-
sed as conventional, whereas 6 (19.4%) as plexiform 
(one plexiform NF arose on the upper lip mucosa of a 
7.5-year-old female patient and was a manifestation of 
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Site  All ONTs (%) GCT (%) NF (%) SCH 
(%) 
TN (%) PEN (%) NSM (%) 
Tongue 81 (52.5) 52 (85.2) 7 (23.3) 9 (31.5) 12 (50.1) 1 (7.7) 0 
• Dorsal tongue 47 (30.5) 34 (55.7) 3 (10) 3 (12.5) 7 (29.2) 0 0 
• Lateral tongue 24 (15.6) 13 (21.3) 4 (13.3) 3 (12.5) 4 (16.7) 0 0 
• Tip of tongue 6 (3.9) 2 (3.3) 0 2 (8.3) 1 (4.2) 1 (7.7) 0 
• Ventral tongue 3 (1.9) 2 (3.3) 0 1 (4.2) 0 0 0 
• Not specified 1 (0.6) 1 (1.6) 0 0 0 0 0 
Hard Palate 18 (11.7) 1 (1.6) 7 (23.3) 1 (4.2) 3 (12.5) 5 (38.5) 1 (50) 
Lip mucosa 19 (12.3) 1 (1.6) 3 (10) 5 (20.8) 5 (20.9) 4 (30.8) 1(50) 
• Lower lip 14 (9.1) 0 2 (6.7) 3 (12.5) 4 (16.7) 4 (30.8) 1(50) 
• Upper lip 5 (3.2) 1 (1.6) 1 (3.3) 2 (8.3) 1 (4.2) 0 0 
Buccal Mucosa 11 (7.1) 2 (3.3) 2 (6.7) 4 (16.7) 1 (4.2) 2 (15.4) 0 
Alveolar Mucosa 7 (4.5) 1 (1.6) 3 (10) 2 (8.3) 1 (4.2) 0 0 
Gingiva 5 (3.2) 0 4 (13.3) 1 (4.2) 0 0 0 
Floor of mouth 3 (1.9) 3 (4.9) 0 0 0 0 0 
Retromolar pad 2 (1.3) 1 (1.6) 0 0 0 1 (7.7) 0 
Muccobuccal fold 2 (1.3) 0 0 2 (8.3) 0 0 0 
Commissure 1 (0.6) 0 1 (3.3) 0 0 0 0 
Intraosseous  5 (3.2) 0 3 (10) 0 2 (8.3) 0 0 
• Mandible 4 (2.6) 0 2 (6.7) 0 2 (8.3) 0 0 
• Maxilla 1 (0.6) 0 1 (3.3) 0 0 0 0 
All sites 154 (100) 61 (100) 30 (100) 24 (100) 24 (100) 13 (100) 2 (100) 
 
Table 2: Location of 154 ONTs.
the already diagnosed neurofibromatosis type 1 (NF1) 
syndrome. We do not know if any of the other patients 
with plexiform NF at the time of diagnosis fulfilled the 
diagnostic criteria of NF1 since we acquired the data 
from the biopsy submission forms; 21 (84%) cases of 
SCH were classified as conventional, 2 (8%) cases as 
plexiform (We do not know if any of the patients with 
plexiform SCH at the time of diagnosis fulfilled the 
diagnostic criteria of neurofibromatosis type II (NF2) or 
schwannomatosis, since we acquired the data from the 
biopsy submission forms) and 2 (8%) as ancient; finally, 
12 (92.3%) cases of PEN were classified as classic or 
lobular and 1 (7.7%) as plexiform.
Discussion
In this retrospective study the demographic, clinical and 
histopathologic characteristics of 157 ONTs were des-
cribed. In Table 4, the number of cases of each ONT 
in our study as well as in similar ones of the literature 
(5-10), are tabulated. Upon combing the data of the stu-
dies of Table 4 that included GCT, NF, SCH, TN and 
PEN on their sample (current study, 6-9), ONTs repre-
sent 0.7% of all specimens from the oral and maxillofa-
cial area submitted for histopathologic examination and 
the most common ONT is NF (38.2%) followed by TN 
(30%), GCT (15.4%), SCH (12.2%), PEN (2.8%), other 
benign ONT (0.9%) and finally malignant peripheral 
nerve sheath tumors (0.4%). In our study, GCT was the 
most common ONT (38.9%) followed by NF (19.7%). 
As can be easily noticed, there are many minor differen-
ces concerning the frequency of each ONT amongst the 
different studies included in Table 4 that can be probably 
explained by the differences in the number of patients 
included and the country of origin of each study (10).
In the following paragraphs, a review of the literature 
concerning ONTs found in our department will be dis-
played.
-Neurofibroma
NF is less prevalent than schwannoma in the head and 
neck area, whereas the opposite applies when they occur 
intraorally (21). It is the first (6,7,9,10) or second (5,8, 
current study) most common ONT. In the majority of ca-
ses, it arises in soft tissues, while it is very rare to appear 
in the jaws (22). It usually appear in the palate, gingiva 
and tongue (5,11) and clinically presents as solitary and 
less frequently as multiple asymptomatic small sessile 
nodules covered by normal appearing mucosa (21). 
5% (10) – 25% (21) of oral NF arise in the setting of 
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Diagnosis Clinical presentation (cases) [%] Mean maximum 
diameter in cm 
(median) [range] 
{cases} 
Color (cases) [%] Symptoms (cases) 
[%] 
Mean duration in 
months (median) 
[range] {cases} 
All ONTs Nodule (147) [94.2] 
Swelling (4) [2.6] 
Ulcerated nodule (3) [1.9] 
Radiolucency (2) [1.2] 
1±0.7 (1) [0.1 - 4] 
{123} 
Normal (78) [58.6] 
White (39) [29.3] 
Red (9) [6.8] 
Yellow (6) [4.5] 
Blue (1) [0.8] 
No (107) [85.6] 
Yes (18) [14.4] 
25±35.5 (12) [0.25 - 
180] {97} 
GCT Nodule (59) [96.7] 
Ulcerated nodule (2) [3.3] 
0.8±0.4 (0.7) [0.1 
- 2] {44} 
White (26) [46.2] 
Normal (24)[42.9] 
Red (3) [5.4] 
Yellow (3) [5.4] 
No (40) [87] 
Yes (6) [13] 
11.4±13.1 (6) [1 - 54] 
{35} 
NF Nodule (25) [80.6] 
Swelling (4) [12.9] 
Radiolucency (1) [3.2] 
Ulcerated nodule (1) [3.2] 
1.4±1 (1) [0.2 - 3] 
{26} 
Normal (19) [76] 
White (3) [12] 
Red (2) [8] 
Blue (1) [4] 
No (20) [76.9] 
Yes (6) [23.1] 
35.4±48.7 (13.5) [0.25 - 
180] {22} 
SCH Nodule (25) [100] 1.5±0.8 (1.5) [0.6 
- 4] {19} 
Normal (14) [73.7] 
White (3) [15.8] 
Red (1) [5.3] 
Yellow (1) [5.3] 
No (18) [90] 
Yes (2) [10] 
31.5±39.7 (12) [1 - 120] 
{17} 
TN Nodule (23) [95.8] 
Radiolucency (1) [4.2] 
0.9±0.6 (0.7) [0.2 
– 2] {21} 
Normal (13) [61.9] 
White (4) [19] 
Red (3) [14.3] 
Yellow (1) [4.8] 
No (17) [81] 
Yes (4) [19] 
26.4±30.6 (12) [1 - 108] 
{17} 
PEN Nodule (13) [100] 0.7±0.5 (0.5) [0.2 
- 2] {11} 
Normal (7) [63.6] 
White (3) [27.3] 
Yellow (1) [9.1] 
No (11) [100] 
 
45.6±39.4 (42) [2.5- 96] 
{4} 
NSM First case: nodule, 1cm maximum diameter, normal color, 79 months duration, unknown symptomatology 
Second case: nodule, 0.7 cm maximum diameter, no symptoms, 3 months duration, unknown color 
 
Table 3: Clinical characteristics of 157 ONTs.
NF1. A suspicion of NF1 may be raised when multiple 
NFs are noticed in the oral cavity or when NF is of the 
plexiform variant (21). However multiple or plexiform 
NFs may arise in patients without NF1 (23,24)  NF1 
(OMIM #162200) is an autosomal dominant multisys-
tem disorder caused by heterozygous mutations in the 
neurofibromin gene on chromosome 17q11.2 (25). In 
order to set a diagnosis of NF1, any two out of the fo-
llowing criteria must be met (26):
1. Six or more café-au-lait macules (with a greatest dia-
meter of >5 mm in pre-pubertal subjects, or <15 mm in 
post-pubertal subjects)
2. Two or more NFs of any type or one plexiform neu-
rofibroma
3. Freckling in the axillary or inguinal region
4. Optic glioma
5. Two or more Lisch nodules (iris hamartomas)
6. A distinctive osseous lesion such as sphenoid dys-
plasia or thinning of long bone cortex with or without 
pseudoarthrosis
7. A first-degree relative with NF1
Patients with NF1 may have one or more of the fo-
llowing osseous, oral and dental features apart from NF: 
short maxilla or mandible or cranial base, macrocephaly, 
low face height, enlargement of the mandibular canal, 
more frequent Class III dental malocclusions, alterations 
in the temporomandibular joint, gingival enlargement, 
gingiva pigmentation, macroglossia, enlargement of 
fungiform papillae,  impacted, supernumerary, missing, 
or displaced teeth and periapical cementum dysplasia 
(25,27). While NFs in patients with NF1 have a greater 
chance of malignant transformation, this has rarely been 
reported for oral or perioral lesions (27).
Histopathologically, conventional NF is circumscribed 
but non-encapsulated and composed of randomly and 
uniform distributed spindle cells with wavy or serpigi-
















(% of all 
ONTs) 
NF 
(% of all 
ONTs) 
SCH 
(% of all 
ONTs) 
TN 
(% of all 
ONTs) 
PEN 





(% of all 
ONTs) 
MPNSTS 








61 (38.9) 31 (19.7) 25 (15.9) 25 (15.9) 13 (8.3) 2 (1.3) 0 
Alotaiby et al. 
(10) (USA)  
164,578 [1994 - 
2015] 
340 (0.2) 108 (31.8) 123 
(36.2) 
61 (17.9) NR 39 (11.5) 9 (2.6) 0 
Franco et al. (9) 
(Brazil)  
Approximately 
13,000 [1978 - 
2011] 
32 (0.2) 5 (15.6) 8 (25) 7 (21.9) 8 (25) 4 (12.5) 0 0 
Alotaiby and 
Sheddi (8) 
(Saudi Arabia)  
5161 [1984 - 
2015] 
29 (0.6) 5 (17.2) 9 (31) 2 (6.9) 11 (37.9) 2 (6.9) 0 0 
Salla et al. (5) 
(Brazil)  
21,476 [1966 - 
2006] 
35 (0.2) NR 12 (34.3) 4 (11.4) 15 (42.9) 1 (2.9) 0 3 (8.6) 
Jones and 
Franklin (6,7)  
(UK)  
48,413 [1973 - 
2002] 
452 (0.9) 32 (7.1) 208 (46) 48 (10.6) 157 
(34.7) 





670 (0.7) 103 (15.4) 256 
(38.2) 
82 (12.2) 201 (30) 19 (2.8) 6 (0.9) 3 (0.4) 
Abbreviations: MPNSTS, malignant peripheral nerve sheath tumors; NR, not reported 
*Only studies including all of the following: GCT, NF, SCH, TN and PEN 
Table 4: Studies of the literature concerning ONTs.
nous and hyperchromatic nuclei, in a loose collagenous 
stroma, which is often myxoid (1,11). Another charac-
teristic feature is the presence of significant amount of 
mast cells (12). Intraneural NF, has the same micros-
copic features as conventional neurofibroma, while its 
stroma is more collagenous and resembles “shredded ca-
rrots” (12). Plexiform NF consists of expanded tortuous 
nerve branches and bundles of wavy, spindle cells (24). 
In the study of Alotaibi et al. (10), 5% of NFs were of 
the plexiform variant, whereas in the present study they 
represented 19.4% of all neurofibromas.
 Rare histologic variants of NF described in the oral 
cavity are NF with prominent differentiation of Meiss-
ner bodies (28) and the very rare dendritic cell NF with 
pseudorosettes (29).
With the use of silver stains, nerve axons can be visuali-
zed inside the tumor’s stroma (11). Cells in NF are S-100 
(Schwann cells) positive but not in the same extent as 
SCH (11). Some of them are also positive for EMA (per-
ineurial cells), CD34 (endoneurial fibroblasts), type IV 
collagen (expressed by basement membranes of nerve 
sheath cells) and CD68 (putative resident macrophages) 
(11). Salla et al. (1) have also shown that in approxi-
mately 80% of cases, cells of NF are GLUT-1 (perineu-
rial cells) positive, while Koutlas and Scheithauer (12) 
mention that cells stain positively but in varying degree 
for GFAP. From the above it is concluded that cells in 
NF are a mixture of Schwann cells, perineurial cells and 
endoneurial fibroblasts, and the proportion of each type 
of cell, varies amongst different tumors as well as in di-
fferent areas of the same tumor (11). 
-Schwannoma
Head and neck is the most common site where SCH ari-
se (30,31). In the oral cavity, however they are not as 
common as they represent 9.3% (30) – 13.5% (32) of all 
head and neck SCHs. SCH is the third (5-7,9,10,current 
study) or fourth (8) most common ONT. Most common-
ly, it presents as a peripheral lesion, but rarely it may 
arise inside the jawbones (10,33). Its most common sites 
of manifestation are the lips and specifically the lower 
lip (10,11,31) or the buccal mucosa (5,34). Clinically, 
oral SCHs manifest as slow-growing solitary masses co-
vered by normal appearing mucosa that measure a few 
millimeters to many centimeters in diameter (31). Most 
cases are asymptomatic, but pain has been reported in up 
to 1/3 of the cases (30). In rare cases, difficulty in swa-
llowing, speaking or breathing, bleeding, macroglossia, 
or loss of sensation and taste may be mentioned by pa-
tients (31,35,36).
Microscopically, conventional SCHs are usually encap-
sulated tumors (11,30) demonstrating a proliferation of 
cells that are organized in two different architectural 
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tissue patterns (11,13,33,34): the most common Anto-
ni A, characterized by fascicles of spindle-shaped cells 
streaming around acellular eosinophilic areas known as 
Verocay bodies, and the less cellular and less organi-
zed Antoni B, where spindle cells are randomly arran-
ged in a loose myxomatous stroma. In Antoni B areas 
mast cells may be found (12). In the majority of cases, 
Antoni A pattern prevails (11,30) and the term cellular 
SCH has been used by some authors when the tumors 
is composed predominantly or exclusively by Antoni 
A areas without Verocay bodies formation (33). Other 
possible microscopic finding are hyalinized and/or ec-
tatic vessels that may be accompanied by hemosiderin 
deposits and degenerative changes most commonly in 
lost-standing lesions such as hemorrhage, infraction, 
dystrophic calcifications, cyst formation, nuclear atypia 
and hyperchroamasia (13,34,37). When these degenera-
tive changes are noticed, the SCH is termed ancient (37). 
However, these changes are less frequently noticed in 
oral SCHs compared to tumors in other parts of the head 
and neck area (30). Another histologic variant is plexi-
form SCH (13), which is characterized grossly and mi-
croscopically by a multinodular, plexiform pattern, with 
all the essential features of conventional SCH. Alotaibi 
et al. (10) reported that 5% of the SCHs of their study 
were of the ancient and 1.6% of the plexiform variant 
whereas in the present study each of those two histolo-
gic variants accounted for 8% of all SCHs. Other rare 
histologic variants of intraoral SCH include SCH with 
pseudoglandular elements (38), melanotic SCH (39), 
SCH with epithelial induction (40) and neuroblastoma 
– like SCH (41). 
Neural axons may be noticed in the surrounding con-
nective tissue and not inside the lesion (11). The cells 
in SCH are S-100 and collagen IV positive and the stai-
ning is greater in Antoni A compared to Antoni B areas 
(11). The cells are also variably positive for CD68; EMA 
stains only the capsular tissues and not the lesion’s cells; 
CD34 stains Antoni B areas as well as capsular tissues 
whereas Antoni A areas are CD34 negative (11). The 
capsule also stains positive for GLUT-1 (1) and lesional 
cells in approximately 50% of cases are GFAP positive 
(12). The EMA/GLUT-1 positivity of the capsule im-
plies that it originates from the perineurium (1), whereas 
the diffuse stains of lesional cells for S-100 suggest they 
are Schwann cells (11).
Two hereditary syndromes that are related to SCH are 
NF2  and schwannomatosis (13). Oral SCHs are rarely 
associated with these syndromes (42), and the likelihood 
of having either one is greater when the plexiform va-
riant is diagnosed (13).  NF2 (OMIM #101000) is an 
autosomal dominant disorder caused by mutation of the 
NF2 gene on chromosome 22q12.2 (43). Clinically, it is 
characterized by the development of vestibular schwan-
nomas; other cranial, spinal or cutaneous nerve schwan-
nomas; cranial and spinal meningiomas or other central 
nervous system tumors; ocular abnormalities (early on-
set cataracts, optic nerve sheath meningiomas, retinal 
or pigment epithelial hamartomas or both and epithelial 
retinal membranes); skin abnormalities (subcutaneous 
schwannomas, and café au lait pigmentation) (43). A 
patient must fulfill at least one of the following five cri-
teria, in order for NF2 to be diagnosed (44):
1. Bilateral vestibular SCHs in patients <70 years
2. First degree relative family history of NF2 and unila-
teral vestibular SCH in patients <70years
3. First degree relative family history of NF2 or unilate-
ral vestibular SCH and 2 of meningioma, cataract, glio-
ma, neurofibroma, SCH, cerebral calcification (if unila-
teral vestibular SCH + ≥ 2nonintradermal SCHs, need 
negative LZTR1 gene test)
4. Multiple meningiomas (2 or more) and 2 of unilateral 
vestibular SCH, cataract, glioma, neurofibroma, SCH, 
cerebral calcification 
5. Constitutional or mosaic pathogenic NF2 gene muta-
tion in blood or identical mutations in 2 distinct tumors
Schwannomatosis (OMIM #162091) is a rare disorder 
characterized by predisposition to develop multiple 
SCHs (that commonly affect peripheral nerves and the 
spine) and less commonly meningiomas, while the most 
common symptom is chronic pain, either diffuse or local 
(45). The majority of schwannomatosis’ cases are spora-
dic with only 13%-25% being familial (45). Until now 
two predisposition genes for schwannomatosis have 
been identified, SMARCB1 on chromosome 22q11.23 
and LZTR1 on chromosome 22q11.21 (45). Diagnosis 
can be set with the combination of both molecular and 
clinical testing or be only clinical (45):
1. Combined molecular and clinical diagnosis: ≥2 tu-
mors with  loss of heterozygosity on the long arm of 
chromosome 22 and 2 different somatic NF2 mutations 
and ≥2pathologically confirmed SCHs or meningiomas 
or germline SMARCB1 or LZTR1 pathogenic mutation 
and one pathologically confirmed SCH or meningioma
2. Clinical diagnosis: ≥2 non-intradermal SCHs, one pa-
thologically confirmed and no bilateral vestibular SCHs 
by high quality MRI (some mosaic NF2 patients  will 
be included in the diagnosis at a young age and some 
schwannomatosis patients may have unilateral vestibu-
lar SCHs or multiple meningiomas) or one pathologica-
lly confirmed SCH or intracranial meningioma and an 
affected first degree relative
3. Exclusion criteria for schwannomatosis include at 
least one of the following: germline pathologic NF2 mu-
tation; diagnostic criteria for NF2 fulfilled; first degree 
relative with NF2; schwannomas occurring in a region 
of previous radiation therapy.
If upon microscopic examination a hybrid tumor (ha-
ving characteristics of both NF and SCH) or an abun-
dant myxoid stroma are noticed, NF2 or schwannomato-
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sis should be suspected (46). However, in 22.2% of oral 
SCHs not associated with any syndrome, areas resem-
bling NF may also be noticed (30).
-Traumatic Neuroma
TN is the first (5,8,9), second (6,7) or third (current 
study) most frequent ONT. It is a reactive lesion (1) 
and represents a copious growth response to nerve in-
jury (47). The majority of TNs are peripheral and only 
a few cases of intraosseous TNs have been reported in 
the English literature (48). Chrysomali et al. (11) repor-
ted that 9.5% of TNs were intraosseous, whereas in the 
study of Peszkowski and Larsson (49), 24.4% of oral 
TNs were located inside the jaw bones. In our Depart-
ment, only 8.3% of TNs were intraosseous. Clinically, 
TN most commonly manifests as non-ulcerated nodule 
with smooth surface (48) on the tongue, mental fora-
men and lip mucosa (5,11). In 25% - 30% of cases, oral 
TNs are painful (48). In our study, TNs, 19% of TNs 
were painful while the ONT presenting more often with 
symptoms was NF. 
Histopathologically, TN is non encapsulated (12) and 
characterized by numerous bundles of axons, nerve fi-
bers and Schwann cells in a dense fibrous connective 
tissue stroma (1,11). The connective tissue may be mu-
coid and its nature depends on the age of the lesion (12). 
Sometimes ganglion cells may also be noticed (47). 
With the use of silver stain, many axons having parallel 
distribution can be identified inside nerve fascicles (11). 
Immunohistochemically, cells inside nerve fascicles are 
S-100 positive and more than 50% of them reacts posi-
tively for CD57 (myelin-associated glycoprotein) (11). 
The only other ONT that reacts positively for CD57 is 
dendritic cell NF with pseudorosettes (29). EMA stains 
more than 50% of cells in the perineurium, CD34 stains 
cells of the endoneurium (11) and GLUT-1 is always po-
sitive on perineurial cells (1).
-Granular cell tumor
The majority of GCTs manifest in the head and neck 
area with the oral cavity and specifically the tongue be-
ing the most prevalent site (10,18,50,51). Oral GCT is 
the first (current study), second (10), third (8) or fourth 
(6,7,9) most common ONT. 
Microscopically GCT in the majority of cases (57%) 
is poorly circumscribed and constitutes of round, oval, 
polygonal or spindle shaped granular cells with dark or 
vesicular nuclei arranged in sheets, ribbons or islands 
separated by septa of fibrous tissue (18). The granular 
cells may involve or replace the muscle fibers whe-
reas it is not common to envelope nerve bundles (18). 
A common finding in GCT is pseudoepitheliomatous 
hyperplasia (PEH). Alotaibi et al. (10) found PEH in 
6.5% of GCTs, Vered et al. (18) in 25% and in our study 
PEH was recorded in 49.2% of GCT cases. According 
to Vered et al. (18), the difference in the reported rates 
of PEH can probably be attributed to the definition of 
PEH adopted from each author. Immunohistochemistry 
is not necessary for the diagnosis of GCT, as the histo-
pathologic findings are pathognomonic.  Granular cells 
are positive for S-100 in the majority of cases (18,19). 
However when S-100 immunostaining is negative, then 
the lesion, as mentioned in the introduction, is termed 
“primitive polypoidGCT” and is characterized by grea-
ter cytologic atypia and higher mitotic index compared 
to granular cell tumor (20).
In 1998, Fanburg-Smith et al. (52), proposed that GCTs 
fulfilling at least three of the following histopathologic 
criteria should be classified as malignant: nuclear pleo-
morphism; tumor cell spindling; vesicular nuclei with 
large nucleoli; increased nuclear:cytoplasm ratio; necro-
sis; increased mitotic rate (>2 mitoses/10HPF). If one 
or two of the above criteria were fulfilled, GCTs should 
be classified as atypical and benign when none of the 
above criteria presented during microscopic examina-
tion (52). In 2011, Nasser et al. (53), in an attempt to 
simplify the diagnostic criteria of malignant GCT, pro-
posed that when necrosis and/or increased mitotic rate 
(>2 mitoses/10HPF) were present, GCTs had an uncer-
tain malignant potential, whereas when none of the two 
existed microscopically, GCTs were considered benign. 
Nevertheless, because GCTs without atypical histologi-
cal features have showed malignant behavior, Machado 
et al. (54) proposed that metastasis is the only definite 
criterion of malignancy in GCT and that lesions with 
atypical histological features should be termed “with 
increased risk of metastasis” and not “malignant”. In ca-
ses of multiple GCTs, benign histology favors the pos-
sibility of multiple rather than malignant lesions with 
the exception of occurrence in the lymph nodes, bones, 
lungs or liver where malignant GCT should be suspected 
despite the lack of atypical histologic features (54).  The 
same applies for metachronous lesions (50). To the best 
of our knowledge, no case of malignant GCT has been 
reported in the oral cavity.
-Palisaded encapsulated neuroma
PEN (or solitary circumscribed neuroma), is the least 
frequent ONT (5,8-10, current study). Clinically it pre-
sent as small painless nodule more commonly on the 
palate, gingiva and lip mucosa (12). Microscopically, it 
is often mistaken with SCH and less frequently with NF 
as reported by Jordan et al. who after reviewing slides 
of older cases, reclassified 12 SCHs and 4 NFs as PENs 
(55). It can be classified as classic or lobular, which is 
the more frequent histologic variant, or plexiform, fun-
gating and multilobular (12). These histologic variations 
are of neither clinically or biologically significance (12). 
In the majority of cases, palisaded encapsulated neu-
roma is well circumscribed but non-encapsulated (12). 
Cells are spindle and arranged in fascicles that show 
tendency for palisading (11). These fascicles may blend 
with the connective tissue immediately subjacent to the 
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epithelium (12). A characteristic finding is the frequent 
artificial clefting due to tissue shrinkage (12). The stro-
ma is collagenized and rarely mucoid and mast cells 
may be evident in some lesions (12). Axons are present 
in variable amounts and patterns and are better visuali-
zed with special stains (11,12)
The cells react positively with S-100 and always negati-
ve for GFAP (12). EMA in peritumoral tissue in incon-
sistently expressed (11,12) and stains no more than one 
layer of cells (11). Some tumoral cells also stain positive 
for CD34 (11). 
-Nerve sheath myxoma and neurothekeoma
Oral NSM is a rare ONT. In our Department we found 
only two cases of NSM, one of which has been already 
published (56). In a systematic review by Rozza-de-Me-
nezes et al. (14), only 25 cases of NSM could be retrie-
ved until 2012. It has a slight female predilection and 
the mean age of patients is 35.9 years, with the majori-
ty of cases diagnosed in the 4th and 5th decade of life 
(14). Clinically, in the majority of cases, it presents as an 
asymptomatic firm nodule of normal color on the gingi-
va, buccal mucosa or tongue (14). Histologically, NSM 
is well circumscribed but non-encapsulated, and charac-
terized by myxoid nodules of varying shape and size, se-
parated by dense collagenous septa (14,57). The myxoid 
matrix is composed of hyaluronic acid as it reacts po-
sitive in Alcian Blue staining at pH 2.5 (14). The cells 
have a small, ovoid and bland nuclei and are arranged 
in such pattern that give nodules a lamellated or whor-
led appearance (57). In rare instances, cells may have 
their nuclei located in the periphery of the cytoplasmic 
membrane or exhibit multinucleation (57). Also, rare 
histological features are epithlelioid morphology of 
cells, nuclear palisading, Verocay – like formations and 
cystic degeneration (58). Mast cells are frequently seen 
(14). Immunohistochemically, cells react positively for 
S-100, S-100A6 and NSE (non – specific enolase) while 
variably for GFAP, CD57 and NGFR (nerve growth fac-
tor receptor) (14,57). Cells do not react for EMA (14).
Neurothekeoma is a rare lesion that histologically mi-
micks oral NSM (14,57,58). Some authors use the term 
“classic neurothekeoma” for NSM and “cellular neuro-
thekeoma” for neurothekeoma (58). However, by using 
microarray analysis, Sheth et al. (59), showed that NSM 
is genetically closer to SCH while neurothekeoma to fi-
brous histiocytoma. Oral neurothekeoma is a very rare 
lesion with less than ten cases reported (58,60). Clini-
cally, in the majority of cases, oral neurothekeoma has 
a female predominance, patients are in the 2nd or 3rd 
decade of life and clinically presents as an asymptoma-
tic or mildly painful firm nodule of normal color in the 
tongue or gingiva (58,60). Histologically, neurothekeo-
ma is non-encapsulated and poorly circumscribed (57) 
and consists of epithelioid to spindle cells organized in 
nests or bundles separated by dense collagen (58). These 
nests are smaller and more uniformly sized compared 
to the one of nerve sheath myxoma (57). In some cases 
cells may exhibit atypia and/or mitotic activity and the 
nests or stoma may be myxoid (57). There is also a sin-
gle report of desmoplastic variant of neurothekeoma is 
the oral cavity which is characterized by marked stroma 
hyalinization (60). Immunohistochemically, cells react 
positive for S100A6 and NSE and negative for S-100 
(57,58). Vered et al. (58), showed that cells of neuro-
thekeoma react positively for NKI/C3 while the opposi-
te stands for nerve sheath myxoma. Plexiform NF may 
also stain positive for NKI/C3 but less intensely than 
neurothekeoma (58).
Conclusions
Tumors of neural origin are rare in the oral cavity as con-
firmed in this study. They have a female predominance, 
they most commonly occur in the 3rd and 4th decade 
of life and the most common site of occurrence is the 
tongue. Their clinical presentation mimic other common 
oral lesions and thus microscopic examination is the 
only mean to arrive at a definitive diagnosis.
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